Matches in Wikidata for { <http://www.wikidata.org/entity/Q62025943> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q62025943 description "clinical trial" @default.
- Q62025943 description "ensayo clínico" @default.
- Q62025943 description "ensayu clínicu" @default.
- Q62025943 description "klinisch onderzoek" @default.
- Q62025943 description "клінічне випробування" @default.
- Q62025943 description "临床试验" @default.
- Q62025943 name "Efficacy and Safety of Nefecon in Patients With Primary IgA (Immunoglobulin A) Nephropathy" @default.
- Q62025943 type Item @default.
- Q62025943 label "Efficacy and Safety of Nefecon in Patients With Primary IgA (Immunoglobulin A) Nephropathy" @default.
- Q62025943 prefLabel "Efficacy and Safety of Nefecon in Patients With Primary IgA (Immunoglobulin A) Nephropathy" @default.
- Q62025943 P1132 Q62025943-A6A9B5FB-A1BD-4900-9851-7CB4D6828FA0 @default.
- Q62025943 P1476 Q62025943-C3C3C53B-5343-442F-9219-A625B843AD88 @default.
- Q62025943 P17 Q62025943-22A77D24-919D-4353-AC34-16622BE093FB @default.
- Q62025943 P17 Q62025943-3E57DB60-C82A-48A8-9CF4-8EB513CD2BE2 @default.
- Q62025943 P17 Q62025943-4B6ED2EC-828E-4873-A4EF-EB2F31E2B084 @default.
- Q62025943 P17 Q62025943-6A4610EF-54E0-4A30-A6E7-FA2424526FB8 @default.
- Q62025943 P17 Q62025943-8E31AF0A-71A0-4BE0-88C8-D459DFA2F9C5 @default.
- Q62025943 P17 Q62025943-99F2D282-5D30-43F8-A039-AF70452B5C9C @default.
- Q62025943 P17 Q62025943-B53D454D-A0C6-4A3D-8C2F-41765FDE0F02 @default.
- Q62025943 P17 Q62025943-DDF35B40-1780-4F8E-AA32-996D236296DF @default.
- Q62025943 P1813 Q62025943-406B9CB5-35A5-41FC-A61D-72DE8EE39671 @default.
- Q62025943 P2899 Q62025943-2730D1EC-0E6E-4AF1-9541-BE673647746B @default.
- Q62025943 P3098 Q62025943-F37E6DE9-4727-4D29-9518-9E627789F16B @default.
- Q62025943 P31 Q62025943-43047E78-1292-43AD-B949-0DEF2B04C74C @default.
- Q62025943 P580 Q62025943-22B20230-6217-4BAD-83C0-D61FE4D3E67F @default.
- Q62025943 P582 Q62025943-74C45506-FA85-4A33-85A1-4CFB42CBE44A @default.
- Q62025943 P6099 Q62025943-F4160076-8315-4BA7-BFA7-259AE1CA0AD5 @default.
- Q62025943 P8005 Q62025943-C1F6517F-B02B-4393-93BF-27AC05BA4994 @default.
- Q62025943 P8363 Q62025943-3C2AE24F-8BB6-4D6A-8B21-282F3A4FCAA5 @default.
- Q62025943 P1132 "+450" @default.
- Q62025943 P1476 "A Randomized, Double-blind, Placebo Controlled Study to Evaluate Efficacy and Safety of Nefecon in Patients With Primary IgA (Immunoglobulin A) Nephropathy at Risk of Progressing to End-stage Renal Disease (NefIgArd)" @default.
- Q62025943 P17 Q142 @default.
- Q62025943 P17 Q145 @default.
- Q62025943 P17 Q16 @default.
- Q62025943 P17 Q183 @default.
- Q62025943 P17 Q30 @default.
- Q62025943 P17 Q31 @default.
- Q62025943 P17 Q34 @default.
- Q62025943 P17 Q414 @default.
- Q62025943 P1813 "Nefigard" @default.
- Q62025943 P2899 "+18" @default.
- Q62025943 P3098 "NCT03643965" @default.
- Q62025943 P31 Q30612 @default.
- Q62025943 P580 "2018-08-01T00:00:00Z" @default.
- Q62025943 P582 "2020-10-01T00:00:00Z" @default.
- Q62025943 P6099 Q42824827 @default.
- Q62025943 P8005 Q76649708 @default.
- Q62025943 P8363 Q78089383 @default.